Review



rabbit anti-snap23  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher rabbit anti-snap23
    (A) Wide-field fluorescence images of untreated HBE cells (left) and HBE cells with CFTR ΔF508 mutation treated with increasing concentrations of porosomes (0.5, and 1 µg). The scale bar represents 50 µm. DAPI (blue) stains the nuclei, and CFTR (green) highlights the CFTR protein. ( B) Magnify-processed images of the same conditions as in Panel A, showing enhanced resolution and detail of CFTR expression. The scale bar represents 50 µm. ( C) Zoomed-in images of the areas indicated by yellow-dotted boxes in Panel B. These images provide a closer view of CFTR expression in the HBE cells. The scale bar represents 5 µm. (D) Magnify-processed images of CFTR ΔF508-mutated HBE cells treated with increasing doses of porosomes (0.2, 0.5, and 1 µg). This panel shows DAPI (blue), CFTR (green), and <t>SNAP23</t> (red), illustrating the expression and localization of both proteins in response to porosome treatment. The scale bar represents 5 µm in biological scale. B, C and D: The expansion factor is 3.8× (1× PBS).
    Rabbit Anti Snap23, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-snap23/bio_rxiv__2024__09__11__612494-82-23-25
    Average 90 stars, based on 1 article reviews
    rabbit anti-snap23 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Porosome reconstitution therapy: A biologic rescue from cystic fibrosis"

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis

    Journal: bioRxiv

    doi: 10.1101/2024.09.11.612494

    (A) Wide-field fluorescence images of untreated HBE cells (left) and HBE cells with CFTR ΔF508 mutation treated with increasing concentrations of porosomes (0.5, and 1 µg). The scale bar represents 50 µm. DAPI (blue) stains the nuclei, and CFTR (green) highlights the CFTR protein. ( B) Magnify-processed images of the same conditions as in Panel A, showing enhanced resolution and detail of CFTR expression. The scale bar represents 50 µm. ( C) Zoomed-in images of the areas indicated by yellow-dotted boxes in Panel B. These images provide a closer view of CFTR expression in the HBE cells. The scale bar represents 5 µm. (D) Magnify-processed images of CFTR ΔF508-mutated HBE cells treated with increasing doses of porosomes (0.2, 0.5, and 1 µg). This panel shows DAPI (blue), CFTR (green), and SNAP23 (red), illustrating the expression and localization of both proteins in response to porosome treatment. The scale bar represents 5 µm in biological scale. B, C and D: The expansion factor is 3.8× (1× PBS).
    Figure Legend Snippet: (A) Wide-field fluorescence images of untreated HBE cells (left) and HBE cells with CFTR ΔF508 mutation treated with increasing concentrations of porosomes (0.5, and 1 µg). The scale bar represents 50 µm. DAPI (blue) stains the nuclei, and CFTR (green) highlights the CFTR protein. ( B) Magnify-processed images of the same conditions as in Panel A, showing enhanced resolution and detail of CFTR expression. The scale bar represents 50 µm. ( C) Zoomed-in images of the areas indicated by yellow-dotted boxes in Panel B. These images provide a closer view of CFTR expression in the HBE cells. The scale bar represents 5 µm. (D) Magnify-processed images of CFTR ΔF508-mutated HBE cells treated with increasing doses of porosomes (0.2, 0.5, and 1 µg). This panel shows DAPI (blue), CFTR (green), and SNAP23 (red), illustrating the expression and localization of both proteins in response to porosome treatment. The scale bar represents 5 µm in biological scale. B, C and D: The expansion factor is 3.8× (1× PBS).

    Techniques Used: Fluorescence, Mutagenesis, Expressing

    Related Articles

    Incubation:

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Post-homogenization, the samples were stained by incubating with primary antibodies (1:250 dilution) in a staining buffer (2X SSC, 1X PBS): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 1.5 hours at room temperature or 1 hour at 37°C.

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Cells were incubated with a staining buffer (2X SSC, 0.2% Tween-20, 1X PBS) containing primary antibodies (1:500 dilution): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 45 minutes to 1 hour at room temperature.

    Staining:

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Post-homogenization, the samples were stained by incubating with primary antibodies (1:250 dilution) in a staining buffer (2X SSC, 1X PBS): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 1.5 hours at room temperature or 1 hour at 37°C.

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Cells were incubated with a staining buffer (2X SSC, 0.2% Tween-20, 1X PBS) containing primary antibodies (1:500 dilution): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 45 minutes to 1 hour at room temperature.

    Fluorescence:

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Post-homogenization, the samples were stained by incubating with primary antibodies (1:250 dilution) in a staining buffer (2X SSC, 1X PBS): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 1.5 hours at room temperature or 1 hour at 37°C.

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Cells were incubated with a staining buffer (2X SSC, 0.2% Tween-20, 1X PBS) containing primary antibodies (1:500 dilution): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 45 minutes to 1 hour at room temperature.

    Mutagenesis:

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Post-homogenization, the samples were stained by incubating with primary antibodies (1:250 dilution) in a staining buffer (2X SSC, 1X PBS): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 1.5 hours at room temperature or 1 hour at 37°C.

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Cells were incubated with a staining buffer (2X SSC, 0.2% Tween-20, 1X PBS) containing primary antibodies (1:500 dilution): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 45 minutes to 1 hour at room temperature.

    Expressing:

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Post-homogenization, the samples were stained by incubating with primary antibodies (1:250 dilution) in a staining buffer (2X SSC, 1X PBS): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 1.5 hours at room temperature or 1 hour at 37°C.

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis
    Article Snippet: Cells were incubated with a staining buffer (2X SSC, 0.2% Tween-20, 1X PBS) containing primary antibodies (1:500 dilution): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 45 minutes to 1 hour at room temperature.



    Similar Products

    94
    Proteintech rabbit polyclonal anti snap23
    Rabbit Polyclonal Anti Snap23, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-snap23/SNAP23+Antibody/pmc12811313-19-0-9
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti snap23 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology snap23
    Knockdown of Q-SNARE STX3, STX4 and <t>SNAP23</t> inhibits eHSP90α secretion. A Immunoblotting HSP90α and STX3 in supernatants and cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against STX3 followed by treatment with 10 ng/ml TGF-β2 for 4 h. B Quantitation of eHSP90α vs. total HSP90α in Fig. 5A by Image J. C Immunoblotting HSP90α and STX4 in supernatants and cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against STX4 followed by treatment with 10 ng/ml TGF-β2 for 4 h. D Quantitation of eHSP90α vs. total HSP90α in Fig. 5C. E Immunoblotting HSP90α and SNAP23 in supernatants or cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against SNAP23 followed by treatment with TGF-β2 for 4 h. F Quantitation of eHSP90α vs. total HSP90α in Fig. 5E. All the data shown are mean ± SD, n = 3. One-way ANOVA statistical analysis for Fig. 5B, D and F. *** p < 0.01. N.S., no significance
    Snap23, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-snap23/SNAP23+Rabbit+pAb/pmc12613659-57-9-20
    Average 94 stars, based on 1 article reviews
    snap23 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Proteintech rabbit anti snap 23
    Knockdown of Q-SNARE STX3, STX4 and <t>SNAP23</t> inhibits eHSP90α secretion. A Immunoblotting HSP90α and STX3 in supernatants and cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against STX3 followed by treatment with 10 ng/ml TGF-β2 for 4 h. B Quantitation of eHSP90α vs. total HSP90α in Fig. 5A by Image J. C Immunoblotting HSP90α and STX4 in supernatants and cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against STX4 followed by treatment with 10 ng/ml TGF-β2 for 4 h. D Quantitation of eHSP90α vs. total HSP90α in Fig. 5C. E Immunoblotting HSP90α and SNAP23 in supernatants or cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against SNAP23 followed by treatment with TGF-β2 for 4 h. F Quantitation of eHSP90α vs. total HSP90α in Fig. 5E. All the data shown are mean ± SD, n = 3. One-way ANOVA statistical analysis for Fig. 5B, D and F. *** p < 0.01. N.S., no significance
    Rabbit Anti Snap 23, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-snap23/SNAP23+Antibody/pmc12012171-117-53-55
    Average 94 stars, based on 1 article reviews
    rabbit anti snap 23 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit anti-snap23
    (A) Wide-field fluorescence images of untreated HBE cells (left) and HBE cells with CFTR ΔF508 mutation treated with increasing concentrations of porosomes (0.5, and 1 µg). The scale bar represents 50 µm. DAPI (blue) stains the nuclei, and CFTR (green) highlights the CFTR protein. ( B) Magnify-processed images of the same conditions as in Panel A, showing enhanced resolution and detail of CFTR expression. The scale bar represents 50 µm. ( C) Zoomed-in images of the areas indicated by yellow-dotted boxes in Panel B. These images provide a closer view of CFTR expression in the HBE cells. The scale bar represents 5 µm. (D) Magnify-processed images of CFTR ΔF508-mutated HBE cells treated with increasing doses of porosomes (0.2, 0.5, and 1 µg). This panel shows DAPI (blue), CFTR (green), and <t>SNAP23</t> (red), illustrating the expression and localization of both proteins in response to porosome treatment. The scale bar represents 5 µm in biological scale. B, C and D: The expansion factor is 3.8× (1× PBS).
    Rabbit Anti Snap23, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-snap23/bio_rxiv__2024__09__11__612494-82-23-25
    Average 90 stars, based on 1 article reviews
    rabbit anti-snap23 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Synaptic Systems antibody , anti-snap23 (rabbit polyclonal)
    ( A ) Schematic representation of the proximal biotinylation of proteins by the ICAM-1-BirA * chimeric protein. ( B ) Cells expressing ICAM-1-BirA* or not were incubated with 50 μM biotin for 16 hr, lysed and subjected to a pull-down (PD) assay with neutravidin-agarose. Biotinylated proteins were detected by blot with streptavidin-HRP. ( C ) PD fractions from two experiments were subjected to mass spectrometry analysis. Table shows the proteins identified exclusively in the fraction of HepG2 expressing ICAM-1-BirA * but not in the PD fraction of parental cells. EBP50 proximal interaction with ICAM-1 is validated by western blot in ( A ). ( D ) Proximal interaction of <t>SNAP23,</t> but not of ezrin-radixin-moesin proteins, despite both having been previously described as ICAM-1 interactors ( ; ). ( E ) Cells stably expressing the indicated Flag-tagged EBP50 proteins were cultured for 48 hr, fixed and stained for the FLAG epitope and for F-actin to localized bile canaliculi (BC). Scale bars, 5 μm. ( F ) Cells were incubated with anti-ICAM-1 mAb for 30 min at 4°C, washed and incubated at 37°C for the indicated times. Cells were lysed and soluble and insoluble (pellet) fractions were separated by centrifugation as described in ‘Materials and methods’. The relative distribution of the indicated proteins was analyzed by western blot (left) and quantified (right). Figure 6—figure supplement 1—source data 1. Original file for the western blot analysis in (neutravidin-HRP). Figure 6—figure supplement 1—source data 2. PDF containing and original scan of the relevant western blot (neutravidin-HRP), with the highlighted region squared. Figure 6—figure supplement 1—source data 3. Original file for the western blot analysis in (anti-ICAM-1 and anti-SNAP23). Figure 6—figure supplement 1—source data 4. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 5. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-ERMs, and anti-SNAP23), with the highlighted region squared. Figure 6—figure supplement 1—source data 6. Original file for the western blot analysis in (anti-ICAM-1). Figure 6—figure supplement 1—source data 7. Original file for the western blot analysis in (anti-EBP50). Figure 6—figure supplement 1—source data 8. Original file for the western blot analysis in (anti-tubulin). Figure 6—figure supplement 1—source data 9. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 10. Original file for the western blot analysis in (anti-GAPDH). Figure 6—figure supplement 1—source data 11. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-EBP50, anti-tubulin, anti-ERMs, and anti-GAPDH), with the highlighted region squared.
    Antibody , Anti Snap23 (Rabbit Polyclonal), supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-snap23/snap23+antibody/pmc11006420-27-2-6
    Average 90 stars, based on 1 article reviews
    antibody , anti-snap23 (rabbit polyclonal) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Synaptic Systems antibody rabbit polyclonal anti-snap23
    ( A ) Schematic representation of the proximal biotinylation of proteins by the ICAM-1-BirA * chimeric protein. ( B ) Cells expressing ICAM-1-BirA* or not were incubated with 50 μM biotin for 16 hr, lysed and subjected to a pull-down (PD) assay with neutravidin-agarose. Biotinylated proteins were detected by blot with streptavidin-HRP. ( C ) PD fractions from two experiments were subjected to mass spectrometry analysis. Table shows the proteins identified exclusively in the fraction of HepG2 expressing ICAM-1-BirA * but not in the PD fraction of parental cells. EBP50 proximal interaction with ICAM-1 is validated by western blot in ( A ). ( D ) Proximal interaction of <t>SNAP23,</t> but not of ezrin-radixin-moesin proteins, despite both having been previously described as ICAM-1 interactors ( ; ). ( E ) Cells stably expressing the indicated Flag-tagged EBP50 proteins were cultured for 48 hr, fixed and stained for the FLAG epitope and for F-actin to localized bile canaliculi (BC). Scale bars, 5 μm. ( F ) Cells were incubated with anti-ICAM-1 mAb for 30 min at 4°C, washed and incubated at 37°C for the indicated times. Cells were lysed and soluble and insoluble (pellet) fractions were separated by centrifugation as described in ‘Materials and methods’. The relative distribution of the indicated proteins was analyzed by western blot (left) and quantified (right). Figure 6—figure supplement 1—source data 1. Original file for the western blot analysis in (neutravidin-HRP). Figure 6—figure supplement 1—source data 2. PDF containing and original scan of the relevant western blot (neutravidin-HRP), with the highlighted region squared. Figure 6—figure supplement 1—source data 3. Original file for the western blot analysis in (anti-ICAM-1 and anti-SNAP23). Figure 6—figure supplement 1—source data 4. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 5. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-ERMs, and anti-SNAP23), with the highlighted region squared. Figure 6—figure supplement 1—source data 6. Original file for the western blot analysis in (anti-ICAM-1). Figure 6—figure supplement 1—source data 7. Original file for the western blot analysis in (anti-EBP50). Figure 6—figure supplement 1—source data 8. Original file for the western blot analysis in (anti-tubulin). Figure 6—figure supplement 1—source data 9. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 10. Original file for the western blot analysis in (anti-GAPDH). Figure 6—figure supplement 1—source data 11. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-EBP50, anti-tubulin, anti-ERMs, and anti-GAPDH), with the highlighted region squared.
    Antibody Rabbit Polyclonal Anti Snap23, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-snap23/snap23+antibody/pm38136609-38-67-70
    Average 90 stars, based on 1 article reviews
    antibody rabbit polyclonal anti-snap23 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Synaptic Systems rabbit anti-snap23
    ( A ) Schematic representation of the proximal biotinylation of proteins by the ICAM-1-BirA * chimeric protein. ( B ) Cells expressing ICAM-1-BirA* or not were incubated with 50 μM biotin for 16 hr, lysed and subjected to a pull-down (PD) assay with neutravidin-agarose. Biotinylated proteins were detected by blot with streptavidin-HRP. ( C ) PD fractions from two experiments were subjected to mass spectrometry analysis. Table shows the proteins identified exclusively in the fraction of HepG2 expressing ICAM-1-BirA * but not in the PD fraction of parental cells. EBP50 proximal interaction with ICAM-1 is validated by western blot in ( A ). ( D ) Proximal interaction of <t>SNAP23,</t> but not of ezrin-radixin-moesin proteins, despite both having been previously described as ICAM-1 interactors ( ; ). ( E ) Cells stably expressing the indicated Flag-tagged EBP50 proteins were cultured for 48 hr, fixed and stained for the FLAG epitope and for F-actin to localized bile canaliculi (BC). Scale bars, 5 μm. ( F ) Cells were incubated with anti-ICAM-1 mAb for 30 min at 4°C, washed and incubated at 37°C for the indicated times. Cells were lysed and soluble and insoluble (pellet) fractions were separated by centrifugation as described in ‘Materials and methods’. The relative distribution of the indicated proteins was analyzed by western blot (left) and quantified (right). Figure 6—figure supplement 1—source data 1. Original file for the western blot analysis in (neutravidin-HRP). Figure 6—figure supplement 1—source data 2. PDF containing and original scan of the relevant western blot (neutravidin-HRP), with the highlighted region squared. Figure 6—figure supplement 1—source data 3. Original file for the western blot analysis in (anti-ICAM-1 and anti-SNAP23). Figure 6—figure supplement 1—source data 4. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 5. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-ERMs, and anti-SNAP23), with the highlighted region squared. Figure 6—figure supplement 1—source data 6. Original file for the western blot analysis in (anti-ICAM-1). Figure 6—figure supplement 1—source data 7. Original file for the western blot analysis in (anti-EBP50). Figure 6—figure supplement 1—source data 8. Original file for the western blot analysis in (anti-tubulin). Figure 6—figure supplement 1—source data 9. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 10. Original file for the western blot analysis in (anti-GAPDH). Figure 6—figure supplement 1—source data 11. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-EBP50, anti-tubulin, anti-ERMs, and anti-GAPDH), with the highlighted region squared.
    Rabbit Anti Snap23, supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-snap23/snap23+antibody/pmc10735228-312-69-76
    Average 90 stars, based on 1 article reviews
    rabbit anti-snap23 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Knockdown of Q-SNARE STX3, STX4 and SNAP23 inhibits eHSP90α secretion. A Immunoblotting HSP90α and STX3 in supernatants and cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against STX3 followed by treatment with 10 ng/ml TGF-β2 for 4 h. B Quantitation of eHSP90α vs. total HSP90α in Fig. 5A by Image J. C Immunoblotting HSP90α and STX4 in supernatants and cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against STX4 followed by treatment with 10 ng/ml TGF-β2 for 4 h. D Quantitation of eHSP90α vs. total HSP90α in Fig. 5C. E Immunoblotting HSP90α and SNAP23 in supernatants or cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against SNAP23 followed by treatment with TGF-β2 for 4 h. F Quantitation of eHSP90α vs. total HSP90α in Fig. 5E. All the data shown are mean ± SD, n = 3. One-way ANOVA statistical analysis for Fig. 5B, D and F. *** p < 0.01. N.S., no significance

    Journal: Cell Communication and Signaling : CCS

    Article Title: TGF-β2 increases eHSP90α secretion via upregulating secretory autophagy pathway

    doi: 10.1186/s12964-025-02493-5

    Figure Lengend Snippet: Knockdown of Q-SNARE STX3, STX4 and SNAP23 inhibits eHSP90α secretion. A Immunoblotting HSP90α and STX3 in supernatants and cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against STX3 followed by treatment with 10 ng/ml TGF-β2 for 4 h. B Quantitation of eHSP90α vs. total HSP90α in Fig. 5A by Image J. C Immunoblotting HSP90α and STX4 in supernatants and cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against STX4 followed by treatment with 10 ng/ml TGF-β2 for 4 h. D Quantitation of eHSP90α vs. total HSP90α in Fig. 5C. E Immunoblotting HSP90α and SNAP23 in supernatants or cell lysates of SRA01/04 that were transfected with scramble siRNA or siRNA against SNAP23 followed by treatment with TGF-β2 for 4 h. F Quantitation of eHSP90α vs. total HSP90α in Fig. 5E. All the data shown are mean ± SD, n = 3. One-way ANOVA statistical analysis for Fig. 5B, D and F. *** p < 0.01. N.S., no significance

    Article Snippet: Rabbit anti-ATG7 (A19604), anti-SEC22B (A15358), anti-STX3 (A3712), anti-STX4 (A5996), SNAP23 (A13909), anti-pan Akt (A18675) and anti-p38 (A14401) antibodies were from Abclonal Technology (Wuhan, China).

    Techniques: Knockdown, Western Blot, Transfection, Quantitation Assay

    (A) Wide-field fluorescence images of untreated HBE cells (left) and HBE cells with CFTR ΔF508 mutation treated with increasing concentrations of porosomes (0.5, and 1 µg). The scale bar represents 50 µm. DAPI (blue) stains the nuclei, and CFTR (green) highlights the CFTR protein. ( B) Magnify-processed images of the same conditions as in Panel A, showing enhanced resolution and detail of CFTR expression. The scale bar represents 50 µm. ( C) Zoomed-in images of the areas indicated by yellow-dotted boxes in Panel B. These images provide a closer view of CFTR expression in the HBE cells. The scale bar represents 5 µm. (D) Magnify-processed images of CFTR ΔF508-mutated HBE cells treated with increasing doses of porosomes (0.2, 0.5, and 1 µg). This panel shows DAPI (blue), CFTR (green), and SNAP23 (red), illustrating the expression and localization of both proteins in response to porosome treatment. The scale bar represents 5 µm in biological scale. B, C and D: The expansion factor is 3.8× (1× PBS).

    Journal: bioRxiv

    Article Title: Porosome reconstitution therapy: A biologic rescue from cystic fibrosis

    doi: 10.1101/2024.09.11.612494

    Figure Lengend Snippet: (A) Wide-field fluorescence images of untreated HBE cells (left) and HBE cells with CFTR ΔF508 mutation treated with increasing concentrations of porosomes (0.5, and 1 µg). The scale bar represents 50 µm. DAPI (blue) stains the nuclei, and CFTR (green) highlights the CFTR protein. ( B) Magnify-processed images of the same conditions as in Panel A, showing enhanced resolution and detail of CFTR expression. The scale bar represents 50 µm. ( C) Zoomed-in images of the areas indicated by yellow-dotted boxes in Panel B. These images provide a closer view of CFTR expression in the HBE cells. The scale bar represents 5 µm. (D) Magnify-processed images of CFTR ΔF508-mutated HBE cells treated with increasing doses of porosomes (0.2, 0.5, and 1 µg). This panel shows DAPI (blue), CFTR (green), and SNAP23 (red), illustrating the expression and localization of both proteins in response to porosome treatment. The scale bar represents 5 µm in biological scale. B, C and D: The expansion factor is 3.8× (1× PBS).

    Article Snippet: Cells were incubated with a staining buffer (2X SSC, 0.2% Tween-20, 1X PBS) containing primary antibodies (1:500 dilution): mouse anti-CFTR (Invitrogen; MA1-935) and rabbit anti-SNAP23 (Invitrogen; PA5-28936) for 45 minutes to 1 hour at room temperature.

    Techniques: Fluorescence, Mutagenesis, Expressing

    ( A ) Schematic representation of the proximal biotinylation of proteins by the ICAM-1-BirA * chimeric protein. ( B ) Cells expressing ICAM-1-BirA* or not were incubated with 50 μM biotin for 16 hr, lysed and subjected to a pull-down (PD) assay with neutravidin-agarose. Biotinylated proteins were detected by blot with streptavidin-HRP. ( C ) PD fractions from two experiments were subjected to mass spectrometry analysis. Table shows the proteins identified exclusively in the fraction of HepG2 expressing ICAM-1-BirA * but not in the PD fraction of parental cells. EBP50 proximal interaction with ICAM-1 is validated by western blot in ( A ). ( D ) Proximal interaction of SNAP23, but not of ezrin-radixin-moesin proteins, despite both having been previously described as ICAM-1 interactors ( ; ). ( E ) Cells stably expressing the indicated Flag-tagged EBP50 proteins were cultured for 48 hr, fixed and stained for the FLAG epitope and for F-actin to localized bile canaliculi (BC). Scale bars, 5 μm. ( F ) Cells were incubated with anti-ICAM-1 mAb for 30 min at 4°C, washed and incubated at 37°C for the indicated times. Cells were lysed and soluble and insoluble (pellet) fractions were separated by centrifugation as described in ‘Materials and methods’. The relative distribution of the indicated proteins was analyzed by western blot (left) and quantified (right). Figure 6—figure supplement 1—source data 1. Original file for the western blot analysis in (neutravidin-HRP). Figure 6—figure supplement 1—source data 2. PDF containing and original scan of the relevant western blot (neutravidin-HRP), with the highlighted region squared. Figure 6—figure supplement 1—source data 3. Original file for the western blot analysis in (anti-ICAM-1 and anti-SNAP23). Figure 6—figure supplement 1—source data 4. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 5. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-ERMs, and anti-SNAP23), with the highlighted region squared. Figure 6—figure supplement 1—source data 6. Original file for the western blot analysis in (anti-ICAM-1). Figure 6—figure supplement 1—source data 7. Original file for the western blot analysis in (anti-EBP50). Figure 6—figure supplement 1—source data 8. Original file for the western blot analysis in (anti-tubulin). Figure 6—figure supplement 1—source data 9. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 10. Original file for the western blot analysis in (anti-GAPDH). Figure 6—figure supplement 1—source data 11. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-EBP50, anti-tubulin, anti-ERMs, and anti-GAPDH), with the highlighted region squared.

    Journal: eLife

    Article Title: ICAM-1 nanoclusters regulate hepatic epithelial cell polarity by leukocyte adhesion-independent control of apical actomyosin

    doi: 10.7554/eLife.89261

    Figure Lengend Snippet: ( A ) Schematic representation of the proximal biotinylation of proteins by the ICAM-1-BirA * chimeric protein. ( B ) Cells expressing ICAM-1-BirA* or not were incubated with 50 μM biotin for 16 hr, lysed and subjected to a pull-down (PD) assay with neutravidin-agarose. Biotinylated proteins were detected by blot with streptavidin-HRP. ( C ) PD fractions from two experiments were subjected to mass spectrometry analysis. Table shows the proteins identified exclusively in the fraction of HepG2 expressing ICAM-1-BirA * but not in the PD fraction of parental cells. EBP50 proximal interaction with ICAM-1 is validated by western blot in ( A ). ( D ) Proximal interaction of SNAP23, but not of ezrin-radixin-moesin proteins, despite both having been previously described as ICAM-1 interactors ( ; ). ( E ) Cells stably expressing the indicated Flag-tagged EBP50 proteins were cultured for 48 hr, fixed and stained for the FLAG epitope and for F-actin to localized bile canaliculi (BC). Scale bars, 5 μm. ( F ) Cells were incubated with anti-ICAM-1 mAb for 30 min at 4°C, washed and incubated at 37°C for the indicated times. Cells were lysed and soluble and insoluble (pellet) fractions were separated by centrifugation as described in ‘Materials and methods’. The relative distribution of the indicated proteins was analyzed by western blot (left) and quantified (right). Figure 6—figure supplement 1—source data 1. Original file for the western blot analysis in (neutravidin-HRP). Figure 6—figure supplement 1—source data 2. PDF containing and original scan of the relevant western blot (neutravidin-HRP), with the highlighted region squared. Figure 6—figure supplement 1—source data 3. Original file for the western blot analysis in (anti-ICAM-1 and anti-SNAP23). Figure 6—figure supplement 1—source data 4. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 5. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-ERMs, and anti-SNAP23), with the highlighted region squared. Figure 6—figure supplement 1—source data 6. Original file for the western blot analysis in (anti-ICAM-1). Figure 6—figure supplement 1—source data 7. Original file for the western blot analysis in (anti-EBP50). Figure 6—figure supplement 1—source data 8. Original file for the western blot analysis in (anti-tubulin). Figure 6—figure supplement 1—source data 9. Original file for the western blot analysis in (anti-ERMs). Figure 6—figure supplement 1—source data 10. Original file for the western blot analysis in (anti-GAPDH). Figure 6—figure supplement 1—source data 11. PDF containing and original scan of the relevant western blot (anti-ICAM-1, anti-EBP50, anti-tubulin, anti-ERMs, and anti-GAPDH), with the highlighted region squared.

    Article Snippet: Antibody , Anti-SNAP23 (rabbit polyclonal) , Synaptic Systems , 111 202; RRID: AB_887788 , WB 1/1000; IF 1/400.

    Techniques: Expressing, Incubation, Mass Spectrometry, Western Blot, Stable Transfection, Cell Culture, Staining, FLAG-tag, Centrifugation

    Journal: eLife

    Article Title: ICAM-1 nanoclusters regulate hepatic epithelial cell polarity by leukocyte adhesion-independent control of apical actomyosin

    doi: 10.7554/eLife.89261

    Figure Lengend Snippet:

    Article Snippet: Antibody , Anti-SNAP23 (rabbit polyclonal) , Synaptic Systems , 111 202; RRID: AB_887788 , WB 1/1000; IF 1/400.

    Techniques: Isolation, Transfection, Construct, Plasmid Preparation, CRISPR, Purification, Sequencing, Recombinant, Immunohistochemistry, Immunofluorescence, Cryo-EM Sample Prep, Tomography, Immunoprecipitation